Peptides that Regulate Food Intake: Glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats
1 Department of Internal Medicine, Federal Armed Forces Hospital, D-89081 Ulm; and 2 Department of Internal Medicine II, Klinikum rechts der Isar, Technical University, D-81675 Munich, Germany Glucagon-like peptide 1-(7-36) amide (GLP-1) potently inhibits rat feeding behavior after central adminis...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Regulatory, integrative and comparative physiology integrative and comparative physiology, 2003-06, Vol.284 (6), p.1427-R1435 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | 1 Department of Internal Medicine, Federal Armed
Forces Hospital, D-89081 Ulm; and 2 Department of
Internal Medicine II, Klinikum rechts der Isar, Technical University,
D-81675 Munich, Germany
Glucagon-like peptide
1-(7-36) amide (GLP-1) potently inhibits rat feeding
behavior after central administration. Because third ventricular
injection of GLP-1 appeared to be less effective than lateral
ventricular injection, we have reexamined this issue. In addition, we
attempted to identify brain regions other than the paraventricular
nucleus of the hypothalamus that are sensitive toward GLP-1-induced
feeding suppression. Finally, we examined the local role of endogenous
GLP-1 by specific GLP-1 receptor blockade. After lateral ventricular
injection, GLP-1 significantly inhibited food intake of 24-h-fasted
rats in a dose-dependent fashion with a minimal effective dose of 1 µg. After third ventricular injection, GLP-1 (1 µg) was similarly
effective in suppressing food intake, which extends previous findings.
Intracerebral microinjections of GLP-1 significantly suppressed food
intake in the lateral (LH), dorsomedial (DMH), and ventromedial
hypothalamus (VMH), but not in the medial nucleus of the amygdala. The
minimal effective dose of GLP-1 was 0.3 µg at LH sites and 1 µg at
DMH or VMH sites. LH microinjections of
exendin-(9-39) amide, a GLP-1 receptor antagonist, at
1 or 2.5 µg did not alter feeding behavior in 24-h-fasted rats. In
satiated animals, however, a single LH injection of 1 µg
exendin-(9-39) amide significantly augmented food
intake, but only during the first 20 min (0.6 vs. 0.1 g). With
three repeated injections of 2.5 µg exendin-(9-39)
amide every 20 min, 1-h food intake was significantly increased by
300%. These data strongly support and extend the concept of GLP-1 as a
physiological regulator of food intake in the hypothalamus.
glucagon-like peptide 1; exendin-(9-39) amide; feeding behavior; rats; hypothalamus; lateral hypothalamus; ventromedial hypothalamus; dorsomedial hypothalamus; amygdala |
---|---|
ISSN: | 0363-6119 1522-1490 |
DOI: | 10.1152/ajpregu.00479.2002 |